14-87945631-C-T
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM1PM5PP2PP3PP5_Very_Strong
The NM_000153.4(GALC):c.1592G>A(p.Arg531His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,610,354 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R531P) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000153.4 missense
Scores
Clinical Significance
Conservation
Publications
- Krabbe diseaseInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Myriad Women’s Health, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GALC | NM_000153.4 | c.1592G>A | p.Arg531His | missense_variant | Exon 14 of 17 | ENST00000261304.7 | NP_000144.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000527 AC: 8AN: 151924Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000522 AC: 13AN: 248936 AF XY: 0.0000444 show subpopulations
GnomAD4 exome AF: 0.0000384 AC: 56AN: 1458312Hom.: 0 Cov.: 31 AF XY: 0.0000427 AC XY: 31AN XY: 725744 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152042Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74304 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Galactosylceramide beta-galactosidase deficiency Pathogenic:6
The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.005%). Missense variant. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.91; 3Cnet: 0.61). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000167119). Different missense changes at the same codon (p.Arg531Cys, p.Arg531Leu) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000188997, VCV001345348). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. -
Variant summary: GALC c.1592G>A (p.Arg531His) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.2e-05 in 248936 control chromosomes. This frequency is not significantly higher than expected for a pathogenic variant in GALC causing Krabbe Disease (5.2e-05 vs 0.0022), allowing no conclusion about variant significance. c.1592G>A has been reported in the literature in individuals affected with Krabbe Disease (Fu_1999, Xu_2006, Orsini_2016, Fu_2018). Functional studies show that the variant results in a galactocerebrosidase protein that gets trapped in the endoplasmic reticulum due to misfolding (Spratley_2016). Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 531 of the GALC protein (p.Arg531His). This variant is present in population databases (rs200378205, gnomAD 0.05%). This missense change has been observed in individuals with Krabbe disease (PMID: 10234611, 16607461, 26795590, 28976722). This variant is also known as p.Arg515His. ClinVar contains an entry for this variant (Variation ID: 167119). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt GALC protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects GALC function (PMID: 27126738). For these reasons, this variant has been classified as Pathogenic. -
NM_000153.3(GALC):c.1592G>A(R531H) is a missense variant classified as likely pathogenic in the context of Krabbe disease. R531H has been observed in cases of with relevant disease (PMID: 10234611, 16607461, Zheng_2014_(no PMID; abstract)). Functional assessments of this variant are available in the literature (PMID: 10234611, 27126738). R531H has been observed in population frequency databases (gnomAD: EAS 0.04%). In summary, NM_000153.3(GALC):c.1592G>A(R531H) is a missense variant that has functional support for pathogenicity and has been observed more frequently in cases with the relevant disease than in healthy populations. Please note: this variant was assessed in the context of healthy population screening. -
- -
not provided Pathogenic:3
- -
Functional studies found this variant is associated with significantly reduced enzyme activity and impaired localization to the lysosome (PMID: 27126738, 10234611); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 28552323, 24252386, 16607461, 10234611, 26795590, 28976722, 34426522, 35314707, 34531397, 27126738) -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at